Kelly Zou Honored as 2025 Top 100 Data & Analytics Professional
May 19, 2025 – New York, NY — AI4Purpose is proud to announce that its founder, Dr. Kelly Zou, has been named one of the 2025 Top 100 Data & Analytics Professionals by the prestigious OnCon Icon Awards. This honor celebrates leaders who have made a significant impact through innovation, data-driven insights, and community engagement.…
Dr. Kelly Zou Named Guest Editor for Special Issue on Real-World Evidence, Digital Health, and AI
Dr. Kelly H. Zou has been named Guest Editor for the Special Issue of Bioengineering (ISSN 2306-5354) titled: “Advances in Biomedical Analytics: Real-World Evidence, Digital Health, Robotics and Artificial Intelligence.” 🔗 View the special issue This special issue explores cutting-edge innovations in real-world data, digital health technologies, AI, and robotics—paving the way for smarter, more…
Kelly H. Zou to Speak on Multi-Stakeholder Digital Health Collaborations at SCOPE Summit
Dr. Kelly H. Zou, Head of Global Medical Analytics and Real-World Evidence at Viatris and Founder of AI4Purpose, will be a featured speaker at the Multi-Stakeholder Digital Health Partnerships and Collaborations session at the SCOPE Summit. She will highlight Gravitate-Health, a groundbreaking public-private partnership funded by the EU’s Innovative Health Initiative (IHI), emphasizing its role…
IMPACCT RWE Summit Allows Exploration of Future of Real-World Evidence
1,049 words, 6 minutes read time. Kelly H. Zou Kelly H. Zou, Ph.D., PStat® is Founder and CEO, AI4Purpose Inc. and Head of Global Medical Analytics, Real World Evidence, and Health Economics and Outcomes Research, Viatris Inc. She is an elected Fellow of the American Statistical Association and an Accredited Professional Statistician. Previously at Pfizer Inc, she…
Empowering Healthcare with Real-World Data and Artificial Intelligence: Ensuring Responsible Use and Exploring Key Use Cases
975 words, 5 minutes read time. Seray Cicek Seray Cicek holds a MSc in Pharmaceutical Sciences and BASc in Engineering Science (Biomedical) from the University of Toronto. Her graduate studies at Keith Pardee’s lab focused on development of a low-cost diagnostic device for the detection of Zika virus in patient samples, and deployment of these…
AI4Purpose Inc. Team Selected as Semifinalist in 2024 Women’s Health Tech Challenge
AI4Purpose Inc. is thrilled to announce that our talented team of graduate students and young researchers, led by ZhiHeng Shi, Siqi Wang, Xinyi Shang, Huachen Shan, and Yirun Wang, has been named a semifinalist in the prestigious 2024 Women’s Health Tech Challenge hosted by HITLAB. This incredible achievement reflects their dedication and innovation in developing…
From Randomized Trials to Real-World Data: The Evolution of Outcomes Research and the Path Forward
1,190 words, 6 minutes read time. Marc Berger Marc L. Berger, MD, is a semi-retired, part-time consultant and scientific advisor. Until July 2017, he was Vice President, Real World Data and Analytics at Pfizer, Inc. Marc has held senior-level positions in industry including Executive Vice President and Senior Scientist at OptumInsight; Vice President, Global Health…
